EKF Diagnostics Holdings (EKF) Stock Statistics & Valuation Metrics

EKF Diagnostics Holdings has a market cap or net worth of £108.87M. The enterprise value is 101.31 p.

EKF Diagnostics Holdings has 430,333,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

EKF Diagnostics Holdings’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.36%.

The current PE Ratio of EKF Diagnostics Holdings is 53.6. EKF Diagnostics Holdings’s PEG ratio is -0.85.

In the last 12 months, EKF Diagnostics Holdings had revenue of 51.56M and earned 2.12M in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was 9.71M and capital expenditures -1.53M, giving a free cash flow of 8.18M billion.

EKF Diagnostics Holdings pays an annual dividend of 1.2 p, resulting in a dividend yield of ―

EKF Diagnostics Holdings upcoming earnings date is Sep 22, 2026, TBA (Confirmed).

EKF Diagnostics Holdings as a current ratio of 4.16, with Debt / Equity ratio of 2.01%

In the past 12 months, EKF Diagnostics Holdings has paid 4.55M in taxes.

EKF Diagnostics Holdings EV to EBITDA ratio is 8.38, with an EV/FCF ratio of 12.71.

EKF Diagnostics Holdings has £15.83M in cash and marketable securities with £1.39M in debt, giving a net cash position of £14.45M billion.

Gross margin is 51.35%, with operating margin of 13.53%, and net profit margin of 4.12%.

The average price target for EKF Diagnostics Holdings is £35.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy